TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with

Elena Brin1, Katherine Wu1, Eleanor Dagostino1

  • 1Polaris Pharmaceuticals, San Diego, CA, USA.

Oncotarget
|January 18, 2019
PubMed

Insights

A novel fusion protein combining Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) with arginine deiminase (ADI) demonstrates enhanced anti-cancer efficacy. This ADI-TRAIL fusion protein overcomes limitations of TRAIL alone, showing superior tumor regression in preclinical models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces cancer cell apoptosis but faces clinical limitations due to poor pharmacokinetics and resistance.
  • Recombinant TRAIL shows preclinical promise, yet clinical translation is hindered by suboptimal in vivo behavior and acquired resistance mechanisms.

Purpose of the Study:

  • To develop and evaluate a novel fusion protein combining TRAIL with arginine deiminase (ADI) to enhance anti-cancer efficacy and overcome TRAIL resistance.
  • To investigate the synergistic effects and in vivo performance of the ADI-TRAIL fusion protein in preclinical cancer models.

Main Methods:

  • Construction and characterization of an ADI-TRAIL fusion protein.
  • Assessment of fusion protein efficacy in various cancer cell lines and combination studies with standard-of-care drugs.
  • Evaluation of ADI-TRAIL fusion protein's pharmacokinetics, tumor localization, and anti-tumor activity in HCT116 xenograft models.

Main Results:

  • The ADI-TRAIL fusion protein exhibited synergistic effects, downregulating survivin and upregulating DR5 receptor expression, thereby sensitizing cancer cells to apoptosis.
  • The fusion protein demonstrated significant efficacy across multiple cell lines and synergized with certain standard chemotherapeutic agents.
  • In HCT116 xenografts, ADI-TRAIL localized to tumors and induced dose-dependent regression, outperforming recombinant TRAIL at equivalent molar concentrations.

Conclusions:

  • The ADI-TRAIL fusion protein represents a promising therapeutic strategy by combining the apoptotic effects of TRAIL with the sensitizing properties of ADI.
  • This novel fusion protein overcomes key limitations of TRAIL, offering improved pharmacokinetics and enhanced anti-tumor activity.
  • ADI-TRAIL warrants further investigation as a potential next-generation cancer therapeutic agent.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
5.1K
Nuclear Fusion02:45

Nuclear Fusion

The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.8K
RNA Stability01:53

RNA Stability

Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.7K
Nuclear Stability03:18

Nuclear Stability

Protons and neutrons, collectively called nucleons, are packed together tightly in a nucleus. With a radius of about 10−15 meters, a nucleus is quite small compared to the radius of the entire atom, which is about 10−10 meters. Nuclei are extremely dense compared to bulk matter, averaging 1.8 × 1014 grams per cubic centimeter. If the earth’s density were equal to the average nuclear density, the earth’s radius would be only about 200 meters.
To hold positively charged protons together...
23.2K
Genetics of Speciation02:16

Genetics of Speciation

Speciation is the evolutionary process resulting in the formation of new, distinct species—groups of reproductively isolated populations.
21.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.4K